A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease "ARRIVE"

Completed

Phase 3 Results

Results

Trial anticipated to end in 2015 with results available in 2016.